Effects of prophylactic chemotherapy for postmolar trophoblastic disease in patients with complete hydatidiform mole.
An analysis of 233 patients with complete hydatidiform mole admitted to Hacettepe University Hospital between 1964 and 1988 has been carried out. Methotrexate was administered prophylactically to 19 of 120 low-risk and to 52 of 113 high-risk patients. The difference in the incidence of postmolar gestational trophoblastic disease between prophylactically untreated and treated groups of either low-risk (13.9% versus 5.3%, P greater than 0.01) or high-risk (26.2% versus 25.0%, P greater than 0.01) patients was found to be statistically insignificant. Drug toxicity and mortality rates were 16.9% and 2.8%, respectively. It is concluded that prophylactic chemotherapy is not highly effective in the prophylaxis of postmolar gestational trophoblastic disease. Strict follow-up through sensitive betahuman chorionic gonadotropin assays should be the standard management of postmolar patients.
Ayhan
A
A
Department of Obstetrics and Gynecology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Ergeneli
M H
MH
Yüce
K
K
Yapar
E G
EG
Kisnisci
A H
AH
D005260:Female; D006801:Humans; D006828:Hydatidiform Mole / Q000150:complications*; D008727:Methotrexate / Q000627:therapeutic use* / Q000633:toxicity; D011247:Pregnancy; D011379:Prognosis; D012306:Risk; D014328:Trophoblastic Neoplasms / Q000517:prevention & control; D014594:Uterine Neoplasms / Q000517:prevention & control*
D008727:Methotrexate